Veterans Hearing Aid Improvement Act of 2026
The Veterans Hearing Aid Improvement Act of 2026 would direct the Department of Veterans Affairs to launch a two-year demonstration project testing whether FDA-cleared over-the-counter hearing aids should be covered for eligible veterans with mild-to-moderate hearing loss. The project must begin within one year of enactment and compare an over-the-counter hearing aid group with a professionally fitted prescription hearing aid group, with roughly equal numbers of participants in each group. The VA would measure self-reported benefit, speech recognition in noise, and the fiscal impact of making over-the-counter hearing aids permanently available under existing VA hearing-aid authority.
Eligibility is limited to enrolled veterans who are clinically determined by an audiologist to need an over-the-counter hearing aid, have no FDA-specified red flags or contraindications, and have access to a mobile phone and data or Wi-Fi needed to use device features. The project must be carried out at at least two VA medical facilities in different Veterans Integrated Services Networks, with attention to rural and urban access and diverse veteran populations. The bill also requires interim and final reports to Congress and a GAO study on hearing-aid assistance for veterans with mild-to-moderate hearing loss, including recommendations for changes to VA programs and benefits.
The bill would not immediately change permanent VA benefit law, but it would create a new pilot program under title 38 to test whether over-the-counter hearing aids should be covered similarly to prescription hearing aids under section 1707(b). It would also require the VA to gather data on clinical outcomes and costs, and it would direct the Comptroller General to study the broader need for hearing-aid assistance and possible program changes. If the demonstration shows favorable results, it could support future statutory or administrative expansion of VA hearing-aid coverage for veterans with mild-to-moderate hearing loss.
The available context suggests generally positive, bipartisan interest in improving veterans’ access to hearing care, as reflected by the bill’s introduction by multiple House members and its focus on affordability, access, and evidence-based evaluation. There are no recorded committee votes or transcripts in the provided material, so no formal opposition or support statements are available. The structure of the bill indicates a cautious, research-oriented approach rather than an immediate mandate, which may make it more broadly acceptable to stakeholders concerned about cost or clinical appropriateness.
The main policy question is whether the VA should cover over-the-counter hearing aids permanently and, if so, under what conditions. Potential points of contention include the fiscal impact on the VA, whether OTC devices are clinically appropriate for all veterans with mild-to-moderate hearing loss, and whether requiring mobile-phone connectivity could limit access for some veterans. Another possible issue is how to compare OTC devices with audiologist-fitted prescription hearing aids and whether the pilot’s design will produce enough evidence to justify broader coverage. Stakeholders representing consumers with hearing loss are explicitly included in consultation, suggesting that veterans’ advocates and hearing-care professionals may have differing views on access, fitting standards, and cost.